Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Revenue: 2010-2025

Historic Revenue for Heron Therapeutics (HRTX) over the last 11 years, with Sep 2025 value amounting to $38.2 million.

  • Heron Therapeutics' Revenue rose 16.47% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year increase of 12.60%. This contributed to the annual value of $144.3 million for FY2024, which is 13.57% up from last year.
  • Heron Therapeutics' Revenue amounted to $38.2 million in Q3 2025, which was up 2.72% from $37.2 million recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Revenue ranged from a high of $40.8 million in Q4 2024 and a low of $20.0 million during Q1 2021.
  • Its 3-year average for Revenue is $35.1 million, with a median of $34.7 million in 2024.
  • Per our database at Business Quant, Heron Therapeutics' Revenue dropped by 21.19% in 2021 and then surged by 45.38% in 2022.
  • Quarterly analysis of 5 years shows Heron Therapeutics' Revenue stood at $20.7 million in 2021, then skyrocketed by 45.38% to $30.0 million in 2022, then grew by 14.00% to $34.2 million in 2023, then rose by 19.13% to $40.8 million in 2024, then rose by 16.47% to $38.2 million in 2025.
  • Its last three reported values are $38.2 million in Q3 2025, $37.2 million for Q2 2025, and $38.9 million during Q1 2025.